Abbott announced that the AVEIR dual chamber leadless pacemaker system, a dual chamber leadless pacemaker system that treats people with abnormal or slow heart rhythms, has been implanted for the first time at the Montreal Heart Institute, in Montreal, Quebec and Foothills Medical Centre in Calgary, Alberta.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Stifel sees ‘unexpected diabetes tech marriage’ as negative for DexCom, others
- Medtronic announces FDA approval for Simplera CGM and partnership with Abbott
- Abbott announces global partnership with Medtronic
- Cadrenal Therapeutics and Abbott partner to develop anticoagulant tecarfarin
- Jefferies healthcare analyst to hold an analyst/industry conference call